Related Experiment Video
Updated: Jul 30, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Recurring HRAS mutation G12S in Dutch patients with Costello syndrome
M A M van Steensel1, M Vreeburg, C Peels
1Department of Dermatology, University Hospital Maastricht, Maastricht, The Netherlands. mvst@sder.azm.nl
Insights
Costello syndrome (CS) is a rare genetic disorder. Our study identifies a specific HRAS gene mutation (G12S) in Dutch patients, suggesting genetic homogeneity for this condition.
Area of Science:
- Genetics
- Molecular Biology
- Medical Science
Background:
- Costello syndrome (CS) is a rare genetic disorder characterized by multiple congenital anomalies, developmental delays, and specific physical features.
- CS is associated with an increased risk of both benign and malignant tumors.
- Previous research indicates that CS is caused by recurrent mutations in the HRAS gene.
Observation:
- This study analyzed three unrelated Dutch patients diagnosed with Costello syndrome.
- Genetic analysis revealed a consistent G12S mutation in the HRAS gene across all three patients.
- This represents the first genetic analysis of Costello syndrome in Dutch patients.
Findings:
- The identified G12S mutation in the HRAS gene is a recurring cause of Costello syndrome.
- The genetic homogeneity observed in this Dutch cohort suggests a common mutational basis.
- The findings reinforce the role of HRAS gene mutations in the etiology of CS.
Implications:
- These findings contribute to a better understanding of the genetic underpinnings of Costello syndrome.
- Identifying specific mutations can aid in genetic counseling and diagnosis for families affected by CS.
- Further research into HRAS mutations may reveal new therapeutic targets for Costello syndrome and related disorders.
Abstract:
Costello syndrome (CS) is a rare multiple congenital anomaly/mental retardation syndrome characterized by coarse face, loose skin and cardiomyopathy. It is often associated with benign and malignant tumors. Several groups have now demonstrated that CS is caused by recurring mutations in the HRAS gene in different ethnic groups. Here, we describe three unrelated Dutch patients and show that they all have the same mutation, G12S, in HRAS. To our knowledge, our patients are the first Dutch to be analysed. The syndrome seems to be genetically homogeneous. We discuss the pertinent nosology of the syndrome.
Related Concept Videos
Pleiotropy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Gene Conversion
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Huntington Disease l: Introduction

